23 / 64
21
PROGRAMME & EXHIBITION GUIDE |
SCIENTIFIC PROGRAMME
C. Godard, C. Even, L. Lévy-Bachelot, F. Huguet, S. Témam,
M. Schwarzinger
PD-029
Survival of patients with head and neck cancers in France
(EPICORL study)
F. Huguet (France), L. Geoffrois, B. Le Vu, Y. Pointreau, M. Bec,
C. Even, L. Lévy-Bachelot, S. Temam, M. Schwarzinger
PD-030
Quality of life, health status and work in head and neck cancer
survivors treated with radiotherapy
A. Matías-Pérez (Spain), B. G. Díaz de Tudanca, G. Gallego-Herreros,
M. Sánchez-Barba, P. Soria-Carreras, A. Nieto-Palacios,
A. Rodríguez-Gutierrez, L.A. Pérez-Romasanta
PD-031
15:30 Discussant: A. Mäkitie (Finland)
Pharyngeal constrictor muscle dose correlated with dysphagia
after radiotherapy in head and neck
J. Miroir (France), J. Biau, N. Saroul, C. Millardet, M. Lapeyre
PD-032
Cetuximab + RT shows an excellent long term OS in patients with
both high ADCC and high EGFR
M. Merlano (Italy), L. Lattanzio, N. Denaro, D. Vivenza, G. Milano,
R. Vigna Taglianti, A. Merlotti, M. Ferrero, C. Lo Nigro
PD-033
Subsite-dependent prognostic impact of age in patients with
nasopharyngeal and oropharyngeal cancer
E. Orlandi (Italy), G. Infante, R. Granata, N. Iacovelli, R. Miceli,
A. Cavallo, S. Alfieri, C. Bergamini, C. Resteghini, D. Galbiati,
L. Locati, S. Tana, S. Naimo, C. Fallai, L. Licitra, P. Bossi
PD-034
15:45 Discussant: D. Raben (USA)